Brain diseases, including neurodegenerative, cerebrovascular and neuropsychiatric
diseases, have posed a deleterious threat to human health and brought a great burden to …

Abstract Background and Purpose Cluster headache is a relatively rare, disabling primary
headache disorder with a major impact on patients' quality of life. This work presents …

Objective To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve
stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute …

Objective To report efficacy and safety of galcanezumab in adults with chronic cluster
headache. Background Galcanezumab is a humanized monoclonal antibody that binds to …

Cluster headache is an excruciating, strictly one-sided pain syndrome with attacks that last
between 15 minutes and 180 minutes and that are accompanied by marked ipsilateral …

Cluster headache is a debilitating primary headache disorder that affects approximately
0.1% of the population worldwide. Cluster headache attacks involve severe unilateral pain …

The role of the trigeminal system in facial and dural sensitivity has been recognized for a
long time. More recently, the trigeminal system has also been considered a prominent actor …

Stroke is a leading cause of disability worldwide, and in approximately 60% of individuals,
upper limb deficits persist 6 months after stroke. These deficits adversely affect the functional …

Primary headaches are one of the most prevalent neurological disorders and can occur
during a wide range of lifespan. Primary headaches, especially migraine, are cyclic …

Introduction Non-invasive vagus nerve stimulation (nVNS; gammaCore®) has the potential
to prevent migraine days in patients with migraine on the basis of mechanistic rationale and …